Conduit Pharmaceuticals Shares Are Trading Higher After the Company Announced It Entered an Agreement With Sarborg to Leverage AI and Its Cybernetics Platform to Evaluate Key Deliverables Across Multiple Areas of Operations.

Benzinga12/12 21:16

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

GlobeNewswire12/12 20:30

Conduit Pharmaceuticals Files to Sell 75M Shares of Common Stock for Holders

Seeking Alpha11/26 06:20

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga11/22 05:06

What's Going On With Conduit Pharmaceuticals Shares Today?

Benzinga11/22 02:53

Conduit Pharmaceuticals Shares Are Trading Higher After the Company Announced That the Japan Patent Office Granted a Composition of Matter Patent for Its Lead Asset, AZD1656.

Benzinga11/21 20:35